ARTICLE SUMMARY:
The US obesity device market is on the cusp of a rapid expansion following the FDA approval of two intragastric balloon devices this July and August. Start-up EndoPRO Solutions is developing a technology to address the shortcomings of both balloons and duodenal barriers, with its hybrid Antral Anchor device.
Obesity is one of the major public health problems facing the US, with approximately one out of every three people, or about 100 million Americans, considered obese, according to the Centers for Disease Control and Prevention.
